Objective Pain Biomarkers: A New Era
Received Date: May 01, 2025 / Published Date: May 29, 2025
Abstract
This collection of research highlights the critical role of pain biomarkers in objective pain assessment and understanding pain mechanisms. Studies explore various ’omics’ approaches, including proteomic, genomic, and metabolomic techniques, to identify molecular signatures for conditions like neuropathic and inflammatory pain. Emerging biomarkers such as urinary metabolites, cytokines, microRNAs, and glial-derived vesicles are investigated for diagnostic and therapeutic potential. Personalized pain management through genetic and epigenetic markers, alongside pharmacogenomics, is also a key focus, aiming to improve treatment efficacy and patient outcomes.
Keywords: Pain Biomarkers脥戮 Objective Pain Assessment脥戮 Neuropathic Pain脥戮 Inflammatory Pain脥戮 Omics Approaches脥戮 Personalized Pain Management脥戮 Central Sensitization脥戮 Pharmacogenomics脥戮 MicroRNAs脥戮 Glial Cells
Citation: Barnes MT (2025) Objective Pain Biomarkers: A New Era. J Pain Relief 14: 738. Doi: 10.4172/2167-0846.1000738
Copyright: 2025 Michael T. Barnes This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 126
- [From(publication date): 0-0 - May 22, 2026]
- Breakdown by view type
- HTML page views: 87
- PDF downloads: 39
